However, depletion of CDC7 in our advanced prostate cancer cell line led to a decrease in TGF-β1, SMAD3, and MMP9 expressions and therefore targeting CDC7 could also be a method to inhibit TGF-β driven metastasis caused by ADT. Here, SMAD3 is linked to prostate cancer.